Cannabis Testing market size reached USD 1.78 billion in 2023 and is expected to reach USD 4.11 billion by 2030, growing at a CAGR of 12.7 % during the forecast period. Cannabinoids are pharmacologically active compounds obtained from the hemp plant Cannabis sativa. Cannabis is the dried leaves, flowers, stems, and seeds of the cannabis Sativa or cannabis indica plant. This plant has been known to have medicinal importance for thousands of years, mainly as an anti-inflammatory, or to relieve pain, anxiety, or mania. Cannabis is gaining popularity all across the world and it is one of the most used drugs on the globe. Cannabis drug testing has acquired popularity in the pharmaceutical, sports, and legal sectors. All batches of cannabis flowers and products must be sampled and tested by licensed laboratories before being delivered to retailers. Governments' strict regulatory standards to ensure higher product quality are set to accelerate market growth. The United Nations currently estimates that 158.8 million people use cannabis worldwide, creating a whole new market within the pharmaceutical sector. The legal use of cannabis for medical purposes is constantly increasing, although it differs per country based on possession, distribution, production, and medical indications for its consumption. Different states and areas have established their own norms and regulations for what must be tested and printed on cannabis product labeling. Increasing approvals for cannabis-based drugs are expected to fuel the worldwide cannabis testing services market growth over the forecast period. Various market players such as Merck KGaA, Shimadzu Corporation, and PerkinElmer are provides products and software to the cannabis testing industry.To know about the Research Methodology :- Request Free Sample Report
Cannabis Testing Market Dynamics:
Used to treat a variety of neurological and mental conditions Cannabis has been studied in various medical disorders including neurological disorders and it is used for medicinal purposes for more than 4 millennia. The World Health Organization estimates that 450 million people worldwide suffer from mental illnesses and it is one of the main causes of sickness and disability worldwide. The most prevalent mental condition is depression, affecting more than 264 million individuals of all ages all over the world. Cannabis and cannabinoids have been shown to have a positive impact on a variety of neurological disorders in humans, including neuropathic pain, migraine, multiple sclerosis, Parkinson’s disease, Huntington’s disease, and motor neuron disease. Thus the demand for Cannabis is increasing because of rising awareness of using cannabis and increased use of software services for the lab testing of cannabis. Numerous organizations accredit labs that do analytical testing on goods derived from hemp and cannabis. The need for cannabis testing would increase the number of laboratories offering cannabis testing services because testing cannabis products is necessary to prove their safety and effectiveness.Cannabis legalization and government support are boosting the worldwide cannabis testing market. The need for analytical testing of cannabis to ensure its safety before human consumption has grown in recent years as medical cannabis is becoming approved in several nations and states throughout the globe. Growing drug usage for medicinal reasons has contributed to the legalization of cannabis in different countries worldwide. Government agencies in a number of nations in North America, Europe, and South America have strictly legalized the use of medical cannabis for limited purposes in certain forms. About 40 nations worldwide permit the limited or authorized use of marijuana-authorized Ayurveda medicines or prescription distribution. Legal cannabis is beneficial in numerous medical uses, such as decreasing chemotherapy-related nausea, stimulating appetite in AIDS patients, managing muscle spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma. Policymakers have legalized the use of medical cannabis in different countries owing to its medicinal effects. A few government departments are undertaking laboratory investigations on cannabis products to help the cannabis industry's growth. For plant testing, various regulatory authorities have started to set overall restrictions for residual solvents, bug sprays, contaminants, heavy metals, microorganisms, and mycotoxins. It also resulted in the establishment of several new laboratories, mostly in developing regions. Experts in the field estimate that the number of cannabis testing laboratories is expected to rise over the forecast period owing to the drug's growing legalization and rise in the need for analytical tools, software, and testing services for cannabis.
Leading market players are focusing on new product launches that are expected to drive the Cannabis Testing market The increased focus on new product launches by key players in the market is expected to propel the growth of the worldwide cannabis testing services market over the forecast period. For instance, in March 2022, Stade Arzneimittel, a pharmaceutical company in Germany, announced the introduction of its medicinal cannabis portfolio under the CannabiStada brand which contains medical cannabis. Both cannabis flowers and whole extracts have been made available by the organization, especially for people with chronic pain who had not gotten relief from opioid-based conventional treatment. With the launch of cannabistada, Stada Arz became one of the first businesses in the German market to provide medical cannabis.
Recent Developments in Medical Research for Cannabis Testing The growing success of cannabis-based medical products is strongly correlated to the relaxation of the previously insurmountable bureaucratic hurdles along with humans’ ancient relationship with this pharmacologically active plant. Cannabis extracts are growing in medical research; even throughout the pandemic, there has been a steady demand for this machinery. Finally, cannabis dispensaries have been designated as "vital businesses" in numerous American regions. Therefore, it is forecasted that these improvements would have a beneficial impact on the Cannabis Testing market growth. Heavy metals, potency, pesticides, terpene profiles, residual solvents, moisture, microbial and fungal development, and mycotoxins/aflatoxin are tested for in cannabis extracts. There is a lot of use of tools like HPLC, gas chromatography, and liquid chromatography. Techniques for chromatography are frequently used to reduce contamination. They can effectively clean cannabis and hemp extracts of pollutants like fungicides, pesticides, herbicides, synergists, and heavy metals at a reasonable price. Using chromatography, THC levels in cannabis extracts can also be decreased. Numerous additional businesses, like Aurum Labs, WATERS, and CannaSafe Inc., among others, also provide a variety of products. Major corporations' presence is expected to drive market growth owing to the increasing availability of products. High start-up costs for testing facilities for cannabis are expected to hamper the market growth One of the major issues facing this industry is the high start-up expenditures for cannabis testing labs. These labs are required to make large financial investments in the procurement and maintenance of expensive, cutting-edge analytical equipment. The standardization and upgrading of equipment, software requirements, accreditations and certifications (such as ISO certification processes), and the demand for competent persons all increase the cost of operations. Because of the uncertainty surrounding the cannabis testing sector, many banks refuse to provide finance or any other kind of support to these laboratories, which has an even bigger effect. Several municipalities are working on a schedule to apply taxes to cannabis testing facilities. Therefore, maintaining profitable operations after making big investments is a huge problem, particularly for small/start-up cannabis testing laboratories. Analytical equipment with sophisticated features and functions, such as chromatography, spectroscopy, and PCR systems, are more expensive. These instruments may be purchased for anywhere between 100,000 and 500,000 U.S. dollars. Due to their limited funding, small and medium-sized cannabis testing labs are unable to use such expensive methods. Additionally, the cost of maintenance and a number of other indirect costs for these systems raise their overall cost of ownership.
Cannabis Testing Market Segment Analysis:
By Service Type, the Potency testing services led the market in terms of service type in 2023 with a revenue share of 23.7 %. The market is primarily being driven by an increase in the demand for analyzing the potency of various cannabinoids, particularly CBD (Cannabidiol) and Tetra hydro cannabinol (THC) in grown cannabis, as well as an increase in the use of efficient potency testing techniques like Gas Chromatography (GC) and High-Performance Liquid Chromatography (HPLC) for testing samples. By Type, the Potency testing services led the market in terms of service type in 2023 with a revenue share of 23.7 %. The market is primarily being driven by an increase in the demand for analyzing the potency of various cannabinoids, particularly CBD (Cannabidiol) and Tetra hydro cannabinol (THC) in grown cannabis, as well as an increase in the use of efficient potency testing techniques like Gas Chromatography (GC) and High-Performance Liquid Chromatography (HPLC) for testing samples. By End-user, the Cannabis farmers and cultivators held the majority of the market's revenue in 2023, accounting for 64.2% of all sales. Because of official regulations on the amount of THC that can be found in cannabis products in many nations, growers are establishing contracts with testing labs and research institutions. Additionally, these producers must offer several plant varieties at various costs to manufacturers and wholesalers according to their CBD and THC concentrations. These are the main elements promoting the segment's growth.Cannabis Testing Market Regional Insights
In the North American region, the Cannabis Testing market is expected to witness significant growth at a CAGR of 15.7% during the forecast period. The presence of a high number of producers in the area and an increase in testing labs as a result of the strict regulations the government has established for marijuana growers are the main drivers of the market growth in this area. More than 100,000 people in Canada were diagnosed with Parkinson's disease in 2021, and 6,600 additional instances are researched to be diagnosed each year, according to UCB Canada Inc., a significant biopharmaceutical business established in Canada. Approx 60,000 persons in the US receive a Parkinson's disease diagnosis each year, according to the Parkinson's Foundation of America. Products with CBD extracted from cannabis are used to treat some Parkinson's and other neurological illnesses symptoms. These high incidence rates are forecasted to boost market growth. One of the first nations to allow the cultivation and usage of cannabis were Canada. Asia Pacific's cannabis testing market is expected to witness the highest growth during the forecast period. Growing awareness about drug testing and price reduction, the increasing biopharmaceutical sector, rising life science research, rising investments by pharmaceutical and biotechnology firms, the growing number of cannabis testing labs in the country, and the legalization of cannabis for medicinal use are projected to drive the industry during the forecast period. The Europe cannabis testing market is predicted to register a substantial share in the global market during the forecast period owing to the increasing legalization of cannabis in major European countries and the increasing use of the herb in drug production and research in this region.The Cannabis Testing Market report forecasts revenue growth at global, and country levels and provides an analysis of the latest industry trends in each of the sub-segments during the forecast period. MMR has segmented the global Cannabis Testing Market report based on Component, Deployment Mode, Organization Size, End-User, and region. The report contains strategic profiling of top key players in the market, a wide-ranging analysis of their core competencies, and their strategies like new product launches, growths, agreements, joint ventures, partnerships, and acquisitions that apply to the businesses. Our team of analysts can also provide you with data in excel files and pivot tables or can assist you in creating presentations from the data sets available in the report.
Cannabis Testing Industry Ecosystem
Cannabis Testing Market Scope: Inquire Before Buying
Global Cannabis Testing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.78 Bn. Forecast Period 2024 to 2030 CAGR: 12.7 % Market Size in 2030: US $ 4.11 Bn. Segments Covered: by Service Type Potency Testing Terpene Profiling Heavy Metal Testing Pesticide Screening Microscopy Testing Residual Solvent Screening By Product Analytical Instruments Chromatography Liquid Chromatography Gas Chromatography Other Spectroscopy Mass Spectrometry Atomic Spectrometry Others Consumables Chromatography Columns Standard and Crms Sample preparation Products Other Cannabis testing software By End User Cannabis Drug Manufacturers Cannabis Cultivators/Growers Others (Research Institutes & Labs) Cannabis Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Cannabis Testing Market, Key Players are:
1. Saskatchewan Research Council (SRC) 2. SC Labs 3. Steep Hill, Inc. 4. SGS Canada Inc. 5. CW ANALYTICAL 6. PharmLabs 7. Thermo Fisher Scientific, Inc. 8. Waters Corporation 9. LabWare, Inc. 10. CannaSafe Analytics 11. Eurofins Scientific 12. GreenLeaf Lab 13. Agilent Technologies Inc. 14. Shimadzu Scientific Instruments 15. Merck KGaA 16. Restek Corporation 17. PerkinElmer Inc., 18. Danaher Corporation 19. Accelerated Technology Laboratories Inc. 20. Steep Hill Halent Laboratories Inc. 21. Digipath Inc. 22. Pharmlabs LLC. FAQs: 1. Who are the key players in the Cannabis Testing market? Ans. Merck KGaA, Shimadzu Corporation, and PerkinElmer are some of the market players in the Cannabis Testing industry. 2. Which Component segment dominates the Cannabis Testing market? Ans. The Potency Testing segment accounted for the largest share of the global Cannabis Testing market in 2023. 3. Which end-user segment of the global Cannabis Testing market is expected to witness the highest growth? Ans. The Cannabis Cultivators/Growers segment accounted for the highest revenue share due to official regulations on the amount of THC that can be found in cannabis products. 4. How big is the Cannabis Testing market? Ans. The global Cannabis Testing market size reached USD 1.78 billion in 2023 and is expected to reach USD 4.11 billion by 2030, growing at a CAGR of 12.7 % during the forecast period. 5. What are the key regions in the global Cannabis Testing market? Ans. Based On the region, the market has been classified into North America, Europe, Asia Pacific, Middle, East and Africa, and Latin America. North America dominates the global Cannabis Testing market.
1. Cannabis Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.2.1. Cannabis Testing: Market Segmentation 1.2.2. Region Covered 1.3. Executive Summary 1.4. Shareholders 2. Global Cannabis Testing Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Key Development 2.5.6. Market Share 2.6. Industry Ecosystem 2.6.1. Key players in the Cannabis Testing ecosystem 2.6.2. Role of companies in the Cannabis Testing ecosystem 2.7. Upcoming Technological and Advancement Initiatives by Key Players 2.8. Market Structure 2.8.1. Market Leaders 2.8.2. Market Followers 2.8.3. Emerging Players 2.9. Consolidation of the Market 2.9.1. Strategic Initiatives and Developments 2.9.2. Mergers and Acquisitions 2.9.3. Collaborations and Partnerships 2.9.4. Product Launches and Innovations 3. Pricing Analysis: Average Selling Price of Cannabis Testing Offered by Key Players in the Market 4. Cannabis Testing Market: Dynamics 4.1. Cannabis Testing Market Trends by Region 4.1.1. North America Cannabis Testing Market Trends 4.1.2. Europe Cannabis Testing Market Trends 4.1.3. Asia Pacific Cannabis Testing Market Trends 4.1.4. South America Cannabis Testing Market Trends 4.1.5. Middle East & Africa (MEA) Cannabis Testing Market Trends 4.2. Cannabis Testing Market Dynamics by Region 4.2.1.1. Drivers 4.2.1.2. Restraints 4.2.1.3. Opportunities 4.2.1.4. Challenges 4.3. PORTER’s Five Forces Analysis 4.3.1. Threat of New Entrants 4.3.2. Threat of Substitutes 4.3.3. Bargaining Power of Suppliers 4.3.4. Bargaining Power of Buyers 4.3.5. Intensity of Competitive Rivalry 4.4. Value Chain Analysis 4.4.1. Cannabis Testing Market: Value Chain Analysis 4.5. Supply Chain Analysis 4.5.1. Cannabis Testing Market: Supply Chain Analysis 4.6. Ecosystem Analysis 4.6.1. Product 4.6.2. Software 4.6.3. Services 4.6.4. End User(Product & Software) 4.6.5. End Users ( Services) 4.6.6. Regulatory Bodies 4.7. Impact of Trends and Technology Disruption on manufacturer 4.8. Technological Analysis 4.8.1. Key Technologies 4.8.1.1. Liquid Chromatography-Mass Spectrometry (LC-MS) 4.8.1.2. Gas Chromatography-Mass Spectrometry( GC-MS) 4.8.1.3. High-Performance Liquid Chromatography (HPLC) 4.8.1.4. Ultra-High-Performance Liquid Chromatography (UHPLC) 4.8.2. Complementary Technologies 4.8.2.1. Portable testing devices 4.8.3. Adjacent technologies 4.8.3.1. Laboratory information management systems (LIMS) 4.8.3.2. Sample preparation automation 4.8.3.3. Artificial Intelligence 4.9. Key Stakeholder and Buying Criteria 4.9.1. Influence of Stakeholders on the Buying Process for the Top Applications 4.9.2. Key Buying Criteria for Top Applications 4.10. Regulatory Landscape 4.10.1. Regulation by Region 4.10.2. Tariff and Taxes 4.10.3. Regulatory Bodies, Government agencies, and other organization by Region 4.11. Patent Analysis 4.11.1. Top 10 Patent Holders 4.11.2. Top 10 Companies with Highest Number of Patents 4.11.3. Patent Registration Analysis 4.11.4. Number of Patents Granted Still 2024 5. Trade Data Analysis: 5.1.1. Import/ Export of Cannabis Testing 6. Cannabis Testing Market: Global Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 6.1. Global Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 6.1.1. Blanking 6.1.2. Embossing 6.1.3. Bending 6.1.4. Coining 6.1.5. Deep Drawing 6.1.6. Flanging 6.1.7. Others 6.2. Global Cannabis Testing Market Size and Forecast, by Product (2023-2030) 6.2.1. Analytical Instruments 6.2.1.1. Chromatography 6.2.1.1.1. Liquid Chromatography 6.2.1.1.2. Gas Chromatography 6.2.1.1.3. Other 6.2.1.2. Spectroscopy 6.2.1.2.1. Mass Spectrometry 6.2.1.2.2. Atomic Spectrometry 6.2.1.3. Others 6.2.2. Consumables 6.2.2.1. Chromatography Columns 6.2.2.2. Standard and Crms 6.2.2.3. Sample prepration Products 6.2.2.4. Other 6.2.3. Cannabis testing software 6.3. Global Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 6.3.1. Cannabis Drug Manufacturers 6.3.2. Cannabis Cultivators/Growers 6.3.3. Others (Research Institutes & Labs) 6.4. Global Cannabis Testing Market Size and Forecast, by Region (2023-2030) 6.4.1. North America 6.4.2. Europe 6.4.3. Asia Pacific 6.4.4. South America 6.4.5. MEA 7. North America Cannabis Testing Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 7.1. North America Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 7.1.1. Potency Testing 7.1.2. Terpene Profiling 7.1.3. Heavy Metal Testing 7.1.4. Pesticide Screening 7.1.5. Microscopy Testing 7.1.6. Residual Solvent Screening 7.2. North America Cannabis Testing Market Size and Forecast, by Product (2023-2030) 7.2.1. Analytical Instruments 7.2.1.1. Chromatography 7.2.1.1.1. Liquid Chromatography 7.2.1.1.2. Gas Chromatography 7.2.1.1.3. Other 7.2.1.2. Spectroscopy 7.2.1.2.1. Mass Spectrometry 7.2.1.2.2. Atomic Spectrometry 7.2.1.2.3. Others 7.2.2. Consumables 7.2.2.1. Chromatography Columns 7.2.2.2. Standard and Crms 7.2.2.3. Sample prepration Products 7.2.2.4. Other 7.2.3. Cannabis testing software 7.3. North America Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 7.3.1. Cannabis Drug Manufacturers 7.3.2. Cannabis Cultivators/Growers 7.3.3. Others (Research Institutes & Labs) 7.4. North America Cannabis Testing Market Size and Forecast, by Country (2023-2030) 7.4.1. United States 7.4.1.1. United States Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 7.4.1.1.1. Potency Testing 7.4.1.1.2. Terpene Profiling 7.4.1.1.3. Heavy Metal Testing 7.4.1.1.4. Pesticide Screening 7.4.1.1.5. Microscopy Testing 7.4.1.1.6. Residual Solvent Screening 7.4.1.2. United States Cannabis Testing Market Size and Forecast, by Product (2023-2030) 7.4.1.2.1. Analytical Instruments 7.4.1.2.1.1. Chromatography 7.4.1.2.1.1.1. Liquid Chromatography 7.4.1.2.1.1.2. Gas Chromatography 7.4.1.2.1.1.3. Other 7.4.1.2.1.2. Spectroscopy 7.4.1.2.1.2.1. Mass Spectrometry 7.4.1.2.1.2.2. Atomic Spectrometry 7.4.1.2.1.3. Others 7.4.1.2.2. Consumables 7.4.1.2.2.1. Chromatography Columns 7.4.1.2.2.2. Standard and Crms 7.4.1.2.2.3. Sample prepration Products 7.4.1.2.2.4. Other 7.4.1.2.3. Cannabis testing software 7.4.1.3. United States Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 7.4.1.3.1. Cannabis Drug Manufacturers 7.4.1.3.2. Cannabis Cultivators/Growers 7.4.1.3.3. Others (Research Institutes & Labs) 7.4.2. Canada 7.4.2.1. Canada Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 7.4.2.1.1. Potency Testing 7.4.2.1.2. Terpene Profiling 7.4.2.1.3. Heavy Metal Testing 7.4.2.1.4. Pesticide Screening 7.4.2.1.5. Microscopy Testing 7.4.2.1.6. Residual Solvent Screening 7.4.2.2. Canada Cannabis Testing Market Size and Forecast, by Product (2023-2030) 7.4.2.2.1. Analytical Instruments 7.4.2.2.1.1. Chromatography 7.4.2.2.1.1.1. Liquid Chromatography 7.4.2.2.1.1.2. Gas Chromatography 7.4.2.2.1.1.3. Other 7.4.2.2.1.2. Spectroscopy 7.4.2.2.1.2.1. Mass Spectrometry 7.4.2.2.1.2.2. Atomic Spectrometry 7.4.2.2.1.3. Others 7.4.2.2.2. Consumables 7.4.2.2.2.1. Chromatography Columns 7.4.2.2.2.2. Standard and Crms 7.4.2.2.2.3. Sample prepration Products 7.4.2.2.2.4. Other 7.4.2.2.3. Cannabis testing software 7.4.2.3. Canada Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 7.4.2.3.1. Cannabis Drug Manufacturers 7.4.2.3.2. Cannabis Cultivators/Growers 7.4.2.3.3. Others (Research Institutes & Labs) 7.4.3. Mexico 7.4.3.1. Mexico Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 7.4.3.1.1. Potency Testing 7.4.3.1.2. Terpene Profiling 7.4.3.1.3. Heavy Metal Testing 7.4.3.1.4. Pesticide Screening 7.4.3.1.5. Microscopy Testing 7.4.3.1.6. Residual Solvent Screening 7.4.3.2. Mexico Cannabis Testing Market Size and Forecast, by Product (2023-2030) 7.4.3.2.1. Analytical Instruments 7.4.3.2.1.1. Chromatography 7.4.3.2.1.1.1. Liquid Chromatography 7.4.3.2.1.1.2. Gas Chromatography 7.4.3.2.1.1.3. Other 7.4.3.2.1.2. Spectroscopy 7.4.3.2.1.2.1. Mass Spectrometry 7.4.3.2.1.2.2. Atomic Spectrometry 7.4.3.2.1.3. Others 7.4.3.2.2. Consumables 7.4.3.2.2.1. Chromatography Columns 7.4.3.2.2.2. Standard and Crms 7.4.3.2.2.3. Sample prepration Products 7.4.3.2.2.4. Other 7.4.3.2.3. Cannabis testing software 7.4.3.3. Mexico Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 7.4.3.3.1. Cannabis Drug Manufacturers 7.4.3.3.2. Cannabis Cultivators/Growers 7.4.3.3.3. Others (Research Institutes & Labs) 8. Europe Cannabis Testing Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 8.1. Europe Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.2. Europe Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.3. Europe Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4. Europe Cannabis Testing Market Size and Forecast, by Country (2023-2030) 8.4.1. United Kingdom 8.4.1.1. United Kingdom Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.1.2. United Kingdom Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.1.3. United Kingdom Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.2. France 8.4.2.1. France Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.2.2. France Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.2.3. France Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.3. Germany 8.4.3.1. Germany Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.3.2. Germany Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.3.3. Germany Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.4. Italy 8.4.4.1. Italy Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.4.2. Italy Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.4.3. Italy Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.5. Spain 8.4.5.1. Spain Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.5.2. Spain Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.5.3. Spain Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.6. Sweden 8.4.6.1. Sweden Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.6.2. Sweden Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.7. Austria 8.4.7.1. Austria Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.7.2. Austria Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.7.3. Austria Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 8.4.8. Rest of Europe 8.4.8.1. Rest of Europe Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 8.4.8.2. Rest of Europe Cannabis Testing Market Size and Forecast, by Product (2023-2030) 8.4.8.3. Rest of Europe Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9. Asia Pacific Cannabis Testing Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 9.1. Asia Pacific Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.2. Asia Pacific Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.3. Asia Pacific Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4. Asia Pacific Cannabis Testing Market Size and Forecast, by Country (2023-2030) 9.4.1. China 9.4.1.1. China Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.1.2. China Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.1.3. China Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.2. S Korea 9.4.2.1. S Korea Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.2.2. S Korea Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.2.3. S Korea Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.3. Japan 9.4.3.1. Japan Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.3.2. Japan Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.3.3. Japan Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.4. India 9.4.4.1. India Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.4.2. India Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.4.3. India Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.5. Australia 9.4.5.1. Australia Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.5.2. Australia Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.5.3. Australia Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.6. ASEAN 9.4.6.1. ASEAN Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.6.2. ASEAN Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.6.3. ASEAN Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 9.4.7. Rest of Asia Pacific 9.4.7.1. Rest of Asia Pacific Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 9.4.7.2. Rest of Asia Pacific Cannabis Testing Market Size and Forecast, by Product (2023-2030) 9.4.7.3. Rest of Asia Pacific Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 10. South America Cannabis Testing Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 10.1. South America Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 10.2. South America Cannabis Testing Market Size and Forecast, by Product (2023-2030) 10.3. South America Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 10.4. South America Cannabis Testing Market Size and Forecast, by Country (2023-2030) 10.4.1. Brazil 10.4.1.1. Brazil Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 10.4.1.2. Brazil Cannabis Testing Market Size and Forecast, by Product (2023-2030) 10.4.1.3. Brazil Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 10.4.2. Argentina 10.4.2.1. Argentina Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 10.4.2.2. Argentina Cannabis Testing Market Size and Forecast, by Product (2023-2030) 10.4.2.3. Argentina Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 10.4.3. Rest Of South America 10.4.3.1. Rest Of South America Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 10.4.3.2. Rest Of South America Cannabis Testing Market Size and Forecast, by Product (2023-2030) 10.4.3.3. Rest Of South America Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 11. Middle East and Africa Cannabis Testing Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 11.1. Middle East and Africa Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 11.2. Middle East and Africa Cannabis Testing Market Size and Forecast, by Product (2023-2030) 11.3. Middle East and Africa Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 11.4. Middle East and Africa Cannabis Testing Market Size and Forecast, by Country (2023-2030) 11.4.1. South Africa 11.4.1.1. South Africa Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 11.4.1.2. South Africa Cannabis Testing Market Size and Forecast, by Product (2023-2030) 11.4.1.3. South Africa Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 11.4.2. GCC 11.4.2.1. GCC Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 11.4.2.2. GCC Cannabis Testing Market Size and Forecast, by Product (2023-2030) 11.4.2.3. GCC Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 11.4.3. Rest Of MEA 11.4.3.1. Rest Of MEA Cannabis Testing Market Size and Forecast, by Service Type (2023-2030) 11.4.3.2. Rest Of MEA Cannabis Testing Market Size and Forecast, by Product (2023-2030) 11.4.3.3. Rest Of MEA Cannabis Testing Market Size and Forecast, by End-User (2023-2030) 12. Company Profile: Key Players 12.1. PharmLabs 12.1.1. Company Overview 12.1.2. Business Portfolio 12.1.3. Financial Overview 12.1.4. SWOT Analysis (Technological strengths and weaknesses) 12.1.5. Strategic Analysis (Recent strategic moves) 12.1.6. Recent Developments 12.2. Saskatchewan Research Council (SRC) 12.3. SC Labs 12.4. Steep Hill, Inc. 12.5. SGS Canada Inc. 12.6. CW ANALYTICAL 12.7. PharmLabs 12.8. GreenLeaf Lab 12.9. Agilent Technologies Inc. 12.10. Shimadzu Scientific Instruments 12.11. Merck KGaA 12.12. Thermo Fisher Scientific, Inc. 12.13. Waters Corporation 12.14. LabWare, Inc. 12.15. CannaSafe Analytics 12.16. Eurofins Scientific 12.17. 12.18. Restek Corporation 12.19. PerkinElmer Inc., 12.20. Danaher Corporation 12.21. Accelerated Technology Laboratories Inc. 12.22. Steep Hill Halent Laboratories Inc. 12.23. Digipath Inc. 12.24. Pharmlabs LLC. 12.25. Others 13. Key Findings and Analyst Recommendations 13.1. Attractive Opportunities for Players in the Cannabis Testing Market 14. Cannabis Testing Market: Research Methodology 14.1. Market Size Estimation 14.1.1. Market Size Estimation: Bottom-Up Approach 14.1.2. Market Size Estimation: Top-Down Approach 14.2. Market Size Estimation: Supply Side 14.3. Data Triangulation 14.3.1. Cannabis Testing Market: Data Triangulation method 14.4. Growth Forecast 14.5. Recession Analysis
